Filing Flows › NextPlat (NXPL) › Pharmacy Prescription and Other Revenue, Net of PBM Fees revenue
NextPlat (NXPL) Pharmacy Prescription and Other Revenue, Net of PBM Fees revenue by quarter
NextPlat's Pharmacy Prescription and Other Revenue, Net of PBM Fees revenue was $5.6M in Q2 2026 (second quarter 2026), +16% from Q1 2026. Over the last 5 quarters it ranged from $4.8M (Q1 2026) to $9.5M (Q3 2025).
| Quarter | Pharmacy Prescription and Other Revenue, Net of PBM Fees revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $5.6M | +16% | -32% |
| Q1 2026 | $4.8M | -40% | — |
| Q4 2025 | $7.9M | -16% | — |
| Q3 2025 | $9.5M | +16% | — |
| Q2 2025 | $8.2M | — | — |
Q2 2026 at a glance
NextPlat, Q2 2026: revenue $11.9M (-10% year over year), operating margin -1.1%, net loss $144K, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is NextPlat's Pharmacy Prescription and Other Revenue, Net of PBM Fees revenue?
NextPlat's Pharmacy Prescription and Other Revenue, Net of PBM Fees revenue was $5.6M in Q2 2026 (second quarter 2026), +16% from Q1 2026.
How has NextPlat's Pharmacy Prescription and Other Revenue, Net of PBM Fees revenue changed?
Over the last 5 quarters it ranged from $4.8M (Q1 2026) to $9.5M (Q3 2025).